Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia

被引:271
作者
Webster, MK
Donoghue, DJ
机构
[1] UNIV CALIF SAN DIEGO, DEPT CHEM & BIOCHEM, LA JOLLA, CA 92093 USA
[2] UNIV CALIF SAN DIEGO, CTR MOLEC GENET, LA JOLLA, CA 92093 USA
关键词
achondroplasia; FGFR3; Neu; receptor activation; transmembrane domain;
D O I
10.1002/j.1460-2075.1996.tb00384.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Achondroplasia, the most common genetic form of dwarfism, is an autosomal dominant disorder whose underlying mechanism is a defect in the maturation of the cartilage growth plate of long bones, Achondroplasia has recently been shown to result from a Gly to Arg substitution in the transmembrane domain of the fibroblast growth factor receptor 3 (FGFR3), although the molecular consequences of this mutation have not been investigated, By substituting the transmembrane domain of the Neu receptor tyrosine kinase with the transmembrane domains of wild-type and mutant FGFR3, the Arg380 mutation in FGFR3 is shown to activate both the kinase and transforming activities of this chimeric receptor, Residues with side chains capable of participating in hydrogen bond formation, including Glu, Asp, and to a lesser extent, Gin, His and Lys, were able to substitute for the activating Arg380 mutation, The Arg380 point mutation also causes ligand-independent stimulation of the tyrosine kinase activity of FGFR3 itself, and greatly increased constitutive levels of phosphotyrosine on the receptor, These results suggest that the molecular basis of achondroplasia is unregulated signal transduction through FGFR3, which may result in inappropriate cartilage growth plate differentiation and thus abnormal long bone development, Achondroplasia may be one of a number of congenital disorders where constitutive activation of a member of the FGFR family leads to developmental abnormalities.
引用
收藏
页码:520 / 527
页数:8
相关论文
共 49 条
[41]   NEU RECEPTOR DIMERIZATION [J].
STERNBERG, MJE ;
GULLICK, WJ .
NATURE, 1989, 339 (6226) :587-587
[42]  
STOLL C, 1989, CLIN GENET, V35, P88
[43]   THANATOPHORIC DYSPLASIA (TYPE-I AND TYPE-II) CAUSED BY DISTINCT MUTATIONS IN FIBROBLAST GROWTH-FACTOR RECEPTOR-3 [J].
TAVORMINA, PL ;
SHIANG, R ;
THOMPSON, LM ;
ZHU, YZ ;
WILKIN, DJ ;
LACHMAN, RS ;
WILCOX, WR ;
RIMOIN, DL ;
COHN, DH ;
WASMUTH, JJ .
NATURE GENETICS, 1995, 9 (03) :321-328
[44]   SIGNAL TRANSDUCTION BY RECEPTORS WITH TYROSINE KINASE-ACTIVITY [J].
ULLRICH, A ;
SCHLESSINGER, J .
CELL, 1990, 61 (02) :203-212
[45]   A POINT MUTATION IN THE NEU ONCOGENE MIMICS LIGAND INDUCTION OF RECEPTOR AGGREGATION [J].
WEINER, DB ;
LIU, J ;
COHEN, JA ;
WILLIAMS, WV ;
GREENE, MI .
NATURE, 1989, 339 (6221) :230-231
[46]   ENHANCEMENT OF TYROSINE KINASE-ACTIVITY OF THE DROSOPHILA EPIDERMAL GROWTH-FACTOR RECEPTOR HOMOLOG BY ALTERATIONS OF THE TRANSMEMBRANE DOMAIN [J].
WIDES, RJ ;
ZAK, NB ;
SHILO, BZ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 189 (03) :637-645
[47]   APERT SYNDROME RESULTS FROM LOCALIZED MUTATIONS OF FGFR2 AND IS ALLELIC WITH CROUZON SYNDROME [J].
WILKIE, AOM ;
SLANEY, SF ;
OLDRIDGE, M ;
POOLE, MD ;
ASHWORTH, GJ ;
HOCKLEY, AD ;
HAYWARD, RD ;
DAVID, DJ ;
PULLEYN, LJ ;
RUTLAND, P ;
MALCOLM, S ;
WINTER, RM ;
REARDON, W .
NATURE GENETICS, 1995, 9 (02) :165-172
[48]   THE V-SIS PROTEIN RETAINS BIOLOGICAL-ACTIVITY AS A TYPE-II MEMBRANE-PROTEIN WHEN ANCHORED BY VARIOUS SIGNAL ANCHOR DOMAINS, INCLUDING THE HYDROPHOBIC DOMAIN OF THE BOVINE PAPILLOMA-VIRUS E5-ONCOPROTEIN [J].
XU, YF ;
MEYER, AN ;
WEBSTER, MK ;
LEE, BA ;
DONOGHUE, DJ .
JOURNAL OF CELL BIOLOGY, 1993, 123 (03) :549-560
[49]  
YAMADA K, 1992, J BIOL CHEM, V267, P12452